You may also like these news :
Former Pharmaceutical Company Execs Face Federal Probe
The Justice Department signed a deferred prosecution agreement 15 months ago with California biotech company InterMune regarding ex-employees who had engaged in illegal off-label marketing of its osteoporosis drug Actimune. The agreement didn't protect the former executives from prosecution, but the DOJ has seldom gone criminal against executives from other pharma companies that have settled. Now, in a rare turn of events, lawyers close to the InterMune case say charges against the executives are likely.